Drug Trial Radar · NCT06293417
To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM
Last checked: Nov 20, 2026Latest source record: Aug 27, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
3,958
Planned (sponsor's estimate)
Start
Mar 1, 2024
Primary completion
Feb 1, 2027
Study completion Feb 1, 2027
Sponsor
- Lead sponsor
- Korea University Anam HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 5, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this Randomized controlled trials is to assess in the long term efficacy and safety of ezefeno. The primary endpoint are: * major adverse cardiovascular events within 48 months of the trial duration * microvascular events within 48 months of the trial duration
Conditions
- T2DM (Type 2 Diabetes Mellitus)
- Dyslipidemias
Interventions
Ezetimibe/fenofibrate (Ezefeno) and moderate-intensity statinDrug
Treatment group
Dose escalation of moderate-intensity statinDrug
Control group
Primary outcomes
What the sponsor says the trial is designed to measure.
- major adverse cardiovascular events and diabetic microvascular events for 48 monthsTime frame: 48month from baseline
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Korea University Anam Hospital
Seoul, South Korea · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.